Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102066224 | 10206622 | 4 | F | 20160825 | 20140530 | 20160830 | EXP | US-PFIZER INC-2014148887 | PFIZER | 17.00 | YR | F | Y | 0.00000 | 20160830 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102066224 | 10206622 | 1 | PS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 100 MG, DAILY | 21992 | 100 | MG | PROLONGED-RELEASE TABLET | |||||||
| 102066224 | 10206622 | 2 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 50 MG, 2X/DAY | 21992 | 50 | MG | PROLONGED-RELEASE TABLET | BID | ||||||
| 102066224 | 10206622 | 3 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | 21992 | PROLONGED-RELEASE TABLET | |||||||||||
| 102066224 | 10206622 | 4 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | 21992 | PROLONGED-RELEASE TABLET | |||||||||||
| 102066224 | 10206622 | 5 | C | LUTERA | ETHINYL ESTRADIOLLEVONORGESTREL | 1 | UNK | 0 | |||||||||||
| 102066224 | 10206622 | 6 | C | REMERON | MIRTAZAPINE | 1 | 30 MG, UNK | 0 | 30 | MG | |||||||||
| 102066224 | 10206622 | 7 | C | BACLOFEN. | BACLOFEN | 1 | 10 MG, UNK | 0 | 10 | MG | |||||||||
| 102066224 | 10206622 | 8 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | 30 MG, UNK | 0 | 30 | MG | |||||||||
| 102066224 | 10206622 | 9 | C | ONDANSETRON | ONDANSETRON | 1 | UNK | 0 | |||||||||||
| 102066224 | 10206622 | 10 | C | WELLBUTRIN XL | BUPROPION HYDROCHLORIDE | 1 | 100 MG, UNK | 0 | 100 | MG | |||||||||
| 102066224 | 10206622 | 11 | C | ETODOLAC. | ETODOLAC | 1 | 500 MG, UNK | 0 | 500 | MG | |||||||||
| 102066224 | 10206622 | 12 | C | DICYCLOMINE | DICYCLOMINE HYDROCHLORIDE | 1 | 10 MG, UNK | 0 | 10 | MG | |||||||||
| 102066224 | 10206622 | 13 | C | KLONOPIN | CLONAZEPAM | 1 | 0.5 MG, UNK | 0 | .5 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 102066224 | 10206622 | 1 | Depression |
| 102066224 | 10206622 | 2 | Post-traumatic stress disorder |
| 102066224 | 10206622 | 3 | Panic attack |
| 102066224 | 10206622 | 4 | Panic disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 102066224 | 10206622 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 102066224 | 10206622 | Drug dependence | |
| 102066224 | 10206622 | Drug withdrawal syndrome | |
| 102066224 | 10206622 | Headache | |
| 102066224 | 10206622 | Nausea | |
| 102066224 | 10206622 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 102066224 | 10206622 | 1 | 201311 | 0 | ||
| 102066224 | 10206622 | 2 | 20160824 | 0 |